Immunicom Competitors and Similar CompaniesClear all
Immunicom's competitors and similar companies include Shoreline Biosciences, IO Biotech, MaxCyte and TScan Therapeutics.
 Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. |  Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms. |  IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. |  MaxCyte MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. | |
Founding Date | Founding Date 2013 | Founding Date 2020 | Founding Date 2014 | Founding Date 1998 | Founding Date 2018 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations San Diego, US HQ San Diego, US | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations Gaithersburg, US HQ Alderley Edge, GB | Locations Waltham, US HQ |
Employees | Employees 22 | Employees 4716% decrease | Employees 19 | Employees 65 | Employees 7316% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 85.3 m | Valuation ($) 387.9 m | Valuation ($) 251.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $33m (FY, 2025) | Revenue (est.) $10.3m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($95.5m) (FY, 2024) | Net income ($44.6m) (FY, 2025) | Net income ($129.8m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 1.9m (over 6 years ago) | Latest funding round $ 43m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 21.9m | Total funding raised $ 46m | Total funding raised $ 165.9m | Total funding raised $ 31.3m | Total funding raised $ 137.5m |
For sources of this data, please see the company profile
View Company Profiles
Shoreline Biosciences
HQ
San Diego, US
Employees
47↓ 16% decrease
Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.
View companyIO Biotech
HQ
New York, US
Employees
19
IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View companyMaxCyte
HQ
Gaithersburg, US
Employees
65
MaxCyte (formerly known as Theramed) is a cell engineering company focused on providing platform technologies for cell-based research as well as cell therapeutic discovery, development, and commercialization.
View companyTScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View company